299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01100892 (ClinicalTrials.gov)	December 2010	31/3/2010	Cystic Fibrosis - Insulin Deficiency, Early Action	Cystic Fibrosis - Insulin Deficiency, Early Action	Cystic Fibrosis;Diabetes	Drug: Once-daily insulin detemir	Sydney Children's Hospitals Network	John Hunter Children's Hospital;Lady Cilento Children's Hospital, Brisbane;Women's and Children's Ho ...	Active, not recruiting	5 Years	19 Years	All	100	Phase 3	United States;Australia
2	NCT00639626 (ClinicalTrials.gov)	August 2008	14/3/2008	Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)	Use of Levemir® Improves Metabolic and Clinical Status in CFRD	Cystic Fibrosis Related Diabetes	Drug: insulin detemir [rDNA origin] injection	Nationwide Children's Hospital	Novo Nordisk A/S	Terminated	16 Years	45 Years	All	6	Phase 2/Phase 3	United States
3	EUCTR2005-002997-31-GB (EUCTR)	10/08/2006	09/11/2005	A multi-centre randomised trial of insulin detemirin pre-diabetes associated with cystic fibrosis. - ...	A multi-centre randomised trial of insulin detemirin pre-diabetes associated with cystic fibrosis. - ...	Individuals with cystic fibrosis develop diabetes. They exhibit abnormal glucose handling (impaired ...	Product Name: Levemir Penfill	Sheffield Children's NHS Trust	NULL	Not Recruiting			Female: yes Male: yes	40	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United Kingdom

First Previous1Next Last